SMTL ID : 9cdy.1

Crystal structure of DLK with inhibitor bound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x 01: 3-{(3M)-3-[6-amino-5-(trifluoromethoxy)pyridin-3-yl]-1-ethyl-7-oxo-1,7-dihydro-6H-pyrazolo[3,4-c]pyridin-6-yl}-1,5-anhydro-3,4-dideoxy-2-O-methyl-D-erythro-pentitol

01.1: 19 residues within 4Å: Chain A: V.20, G.21, S.22, G.23, Q.25, V.28, L.30, A.39, K.41, I.63, M.79, E.80, F.81, C.82, A.83, Q.84, G.85, Q.86, L.132 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.20, A:V.28, A:V.28, A:F.81, A:L.132 Hydrogen bonds: A:E.80, A:C.82

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: E.13, F.33, H.34 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:E.13, A:H.34, H2O.6

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 8 residues within 4Å: Chain A: K.41, I.51, L.54, F.65, I.77, M.79, D.143, F.144 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.41, A:D.143, A:F.144, A:F.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lagiakos, H.R. et al., In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury. J.Med.Chem. (2024)

Release Date

2025-02-19

Peptides

Mitogen-activated protein kinase kinase kinase 12: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 12

Related Entries With Identical Sequence